Tuberculosis Preventive Therapy for Individuals Exposed to Drug-resistant Tuberculosis: Feasibility and Safety of a Community-based Delivery of Fluoroquinolone-containing Preventive Regimen
- 12 June 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 70 (9) , 1958-1965
Abstract
Observational studies have demonstrated the effectiveness of a fluoroquinolone-based regimen to treat individuals exposed to or presumed to be infected with drug-resistant (DR)-TB. We sought to assess the feasibility of this approach in an urban setting in South Asia. From February 2016 until March 2017, all household contacts of DR-TB patients enrolled at The Indus Hospital were screened for TB symptoms at home. Children 0-17 years, symptomatic adults and those with an immunocompromising condition (HIV, diabetes or malnutrition) were evaluated for TB disease. Contacts diagnosed with TB disease were started on treatment. Contacts without TB disease (i) younger than 5 years; (ii) between 5 and 17 years old with either a positive TST or an immunocompromising condition; or (iii) 18 years and older with an immunocompromising conditionwere offered six month treatment with a fluoroquinolone. One hundred households with 800 contacts were enrolled: 353 (44·1%) individuals age 17 years or younger with a median age of 19 years (IQR: 10-32); 423 (52·9%) were males. In total, 737 (92·1%) individuals were screened, of which eight were already on treatment for TB (1·1%), and another three (0·4%) contacts were diagnosed with TB disease and started on treatment. Of 215 eligible for infection treatment, 172 (80·0%) contacts initiated and 121 (70·3%) completed treatment. No TB disease nor significant adverse events were observed during 12 months of follow up in any group. Fluoroquinolone-based treatment for contacts with presumed DR-TB infection is feasible and well tolerated in a high TB burden setting.Keywords
Funding Information
- Dubai Harvard Foundation
This publication has 22 references indexed in Scilit:
- Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigationThe Lancet Infectious Diseases, 2017
- Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infectionThe Lancet, 2015
- Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, RussiaEmerging Infectious Diseases, 2015
- Tuberculosis—getting to zeroThe Lancet, 2015
- Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009–2012The International Journal of Tuberculosis and Lung Disease, 2014
- High tuberculosis prevalence in children exposed at home to drug-resistant tuberculosisThe International Journal of Tuberculosis and Lung Disease, 2014
- Yield of Contact Investigations in Households of Patients With Drug-Resistant Tuberculosis: Systematic Review and Meta-AnalysisClinical Infectious Diseases, 2013
- Preventive Therapy for Child Contacts of Multidrug-Resistant Tuberculosis: A Prospective Cohort StudyClinical Infectious Diseases, 2013
- Exogenous Reinfection as a Cause of Multidrug‐Resistant and Extensively Drug‐Resistant Tuberculosis in Rural South AfricaThe Journal of Infectious Diseases, 2008
- Management of Pediatric Multidrug-Resistant Tuberculosis and Latent Tuberculosis Infections in New York City From 1995 to 2003The Pediatric Infectious Disease Journal, 2008